These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201 [TBL] [Abstract][Full Text] [Related]
10. Antifibrinolytics and cardiac surgery: The past, the present, and the future. Aggarwal NK; Subramanian A Ann Card Anaesth; 2020; 23(2):193-199. PubMed ID: 32275035 [TBL] [Abstract][Full Text] [Related]
11. Antifibrinolytics in orthotopic liver transplantation: current status and controversies. Xia VW; Steadman RH Liver Transpl; 2005 Jan; 11(1):10-8. PubMed ID: 15690531 [TBL] [Abstract][Full Text] [Related]
12. A review of aprotinin in orthotopic liver transplantation: can its harmful effects offset its beneficial effects? Lentschener C; Roche K; Ozier Y Anesth Analg; 2005 May; 100(5):1248-1255. PubMed ID: 15845662 [TBL] [Abstract][Full Text] [Related]
15. Natural and synthetic antifibrinolytics: inert, poisonous or therapeutic agents? Hardy JF; Bélisle S Can J Anaesth; 1997 Sep; 44(9):913-7. PubMed ID: 9305552 [No Abstract] [Full Text] [Related]
16. Antifibrinolytics in liver transplantation. Groenland TH; Porte RJ Int Anesthesiol Clin; 2006; 44(3):83-97. PubMed ID: 16832208 [No Abstract] [Full Text] [Related]
17. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery. Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013 [TBL] [Abstract][Full Text] [Related]
18. Regional hemostatic status and blood requirements after total knee arthroplasty with and without tranexamic acid or aprotinin. Engel JM; Hohaus T; Ruwoldt R; Menges T; Jürgensen I; Hempelmann G Anesth Analg; 2001 Mar; 92(3):775-80. PubMed ID: 11226117 [TBL] [Abstract][Full Text] [Related]
19. The use of antifibrinolytic agents results in a reduction in transfused blood products during liver transplantation. Ramsay MA Liver Transpl Surg; 1997 Nov; 3(6):665-8. PubMed ID: 9404974 [No Abstract] [Full Text] [Related]
20. Aprotinin and tranexamic acid for high transfusion risk cardiac surgery. Wong BI; McLean RF; Fremes SE; Deemar KA; Harrington EM; Christakis GT; Goldman BS Ann Thorac Surg; 2000 Mar; 69(3):808-16. PubMed ID: 10750765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]